Search Results - Tanios Bekaii-Saab
You must be logged in first
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
Response to Drs Von Hoff and Renschler by Daniel H. Ahn, Tanios Bekaii-Saab
Published 2017-06-01
Article -
3
-
4
Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies by Mohamad B. Sonbol, Daniel H. Ahn, Tanios Bekaii-Saab
Published 2019-03-01
Article -
5
Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vacci... by Pravin T. P. Kaumaya, Linlin Guo, Jay Overholser, Manuel L. Penichet, Tanios Bekaii-Saab
Published 2020-01-01
Article -
6
Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatinand irinotecan-based chemotherapy and biologics in... by Victoria Federico Paly, Arvind Dasari, Joleen Hubbard, Tanios Bekaii-Saab, Thihan Padukkavidana, Luis Hernandez
Published 2024-07-01Article -
7
-
8
-
9
Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer... by Jay Overholser, Kristen Henkins Ambegaokar, Siobhan M. Eze, Eduardo Sanabria-Figueroa, Rita Nahta, Tanios Bekaii-Saab, Pravin T.P. Kaumaya
Published 2015-07-01
Article -
10
A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis by Daniel H. Ahn, Kavya Krishna, Marlo Blazer, Joshua Reardon, Lai Wei, Christina Wu, Kristen K. Ciombor, Anne M. Noonan, Sameh Mikhail, Tanios Bekaii-Saab
Published 2017-02-01
Article -
11
Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure–safety analyses in patients with metastatic pancreatic cancer by Karl Brendel, Tanios Bekaii‐Saab, Patrick M Boland, Farshid Dayyani, Andrew Dean, Teresa Macarulla, Fiona Maxwell, Kabir Mody, Anna Pedret‐Dunn, Zev A Wainberg, Bin Zhang
Published 2021-12-01
Article -
12
Practical considerations in the use of regorafenib in metastatic colorectal cancer by Fotios Loupakis, Lorenzo Antonuzzo, Jean-Baptiste Bachet, Feng-Che Kuan, Teresa Macarulla, Filippo Pietrantonio, Rui-Hua Xu, Hiroya Taniguchi, Thomas Winder, Satoshi Yuki, Shan Zeng, Tanios Bekaii-Saab
Published 2020-10-01
Article -
13
960 Randomized multicenter study of neoadjuvant chemoradiation therapy (CRT) alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancrea... by Tanios Bekaii-Saab, Todd Bauer, Gina Petroni, Osama Rahma, Rawad Elias, Craig Slingluff, Mathew Katz, Brian Wolpin, Chee-Chee Stucky, Andressa Dias-Costa, Jonathan Nowak, Lenehan Patrick, Stephanie Dougan
Published 2021-11-01Article -
14
Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer by Reham Abdel-Wahab, Timothy A. Yap, Russell Madison, Shubham Pant, Matthew Cooke, Kai Wang, Haitao Zhao, Tanios Bekaii-Saab, Elif Karatas, Lawrence N. Kwong, Funda Meric-Bernstam, Mitesh Borad, Milind Javle
Published 2020-12-01
Article -
15
518 First-in-human results with the novel tumor-targeting antibody ATRC-101: phase 1b study in patients with solid tumors by Lixia Wang, John Powderly, Tanios Bekaii-Saab, Susanna Ulahannan, Ngan Nguyen, Deborah Doroshow, Yan Xing, Mark Whidden, Carl Millward, Jonathan Benjamin, S John Weroha, Frances Valdes-Albini, Kimberly Walter, Andrew Wrong, Paul Del Castillo, Steven Isakoff
Published 2021-11-01Article -
16
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials by Mairéad Geraldine McNamara, John Bridgewater, Andre Lopes, Harpreet Wasan, David Malka, Lars Henrik Jensen, Takuji Okusaka, Jennifer J. Knox, Dorothea Wagner, David Cunningham, Jenny Shannon, David Goldstein, Markus Moehler, Tanios Bekaii-Saab, Juan W. Valle
Published 2017-04-01
Article -
17
What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature by David Goldstein, Richard Hubner, Angela Lamarca, Lipika Goyal, Junji Furuse, Tanios Bekaii-Saab, Jennifer Knox, Mairéad G McNamara, Juan Valle, Rachna Shroff, Chigusa Morizane, Lorenza Rimassa, John Bridgewater, Timothy Jacobs, Anna D Wagner, Markus Moehler, Maeve Lowery, Robin K Kelley
Published 2022-10-01
Article -
18
750 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc fusion protein in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers by Lei Zheng, Jun Gong, John Powderly, Tanios Bekaii-Saab, Angela Alistar, Siqing Fu, Nashat Gabrail, Dae Won Kim, Yvonne Saenger, Olatunji Alese, Apollina Goel, Nataliya Uboha, Laura Agensky, Matteo Levisetti, Steven Margossian, Steve Quayle, J Eva Selfridge, Jorge Chaves, Jin Zhaohui
Published 2023-11-01Article -
19
Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, rando... by Tanios Bekaii-Saab, Takuji Okusaka, David Goldstein, Do-Youn Oh, Makoto Ueno, Tatsuya Ioka, Weijia Fang, Eric C. Anderson, Marcus S. Noel, Michele Reni, Hye Jin Choi, Jonathan S. Goldberg, Sang Cheul Oh, Chung-Pin Li, Josep Tabernero, Jian Li, Emma Foos, Cindy Oh, Eric Van Cutsem
Published 2023-04-01
Article -
20
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor by Sophia G Liva, Yu‐Chou Tseng, Anees M Dauki, Michael G Sovic, Trang Vu, Sally E Henderson, Yi‐Chiu Kuo, Jason A Benedict, Xiaoli Zhang, Bryan C Remaily, Samuel K Kulp, Moray Campbell, Tanios Bekaii‐Saab, Mitchell A Phelps, Ching‐Shih Chen, Christopher C Coss
Published 2020-02-01
Article